Results 281 to 290 of about 634,412 (379)

A Phase 1 Randomized Study: Garadacimab Pharmacokinetics, Safety, and Tolerability After Administration via Autoinjector/Pre‐Filled Pen Versus Pre‐Filled Syringe in Healthy Participants

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Garadacimab is a novel, fully human, anti‐activated factor XII monoclonal antibody approved for long‐term prophylaxis of patients with hereditary angioedema. This open‐label, parallel‐group, Phase 1, single‐center, bridging study in healthy adults (18–55 years of age) characterized the pharmacokinetics and safety of a single 200 mg ...
Fiona Glassman   +9 more
wiley   +1 more source

Current Orthodontic Education Status on Treating Patients With ASD and/or ADHD in North America

open access: yesJournal of Dental Education, EarlyView.
ABSTRACT Objectives Autism spectrum disorder (ASD) and attention‐deficit hyperactivity disorder (ADHD) are associated with specific dental and behavioral attributes, particularly in children, that necessitate special attention from healthcare providers.
Nikki Wei   +4 more
wiley   +1 more source

Eosinophilia associated with nintedanib therapy. [PDF]

open access: yesRespir Med Case Rep
Banafshay KA, Mutneja R.
europepmc   +1 more source

Coping with the burden of irritable bowel syndrome by emotional suppression—A cross sectional observational pilot study

open access: yesJournal of General and Family Medicine, EarlyView.
Abstract Background Psychological stress like depression, anxiety, and anger is a common comorbidity of irritable bowel syndrome (IBS). This clinical pilot study aimed to investigate if individuals employ emotional suppression to cope with the psychological burden associated with IBS.
Henning Sommermeyer   +5 more
wiley   +1 more source

Radiation Risk in 2D Mammography Screening: A Scoping Review of Modelling Strategies and Emerging AI Applications

open access: yesJournal of Medical Radiation Sciences, EarlyView.
This scoping review examined models estimating long‐term radiation risks from repeated mammography screening. While modelling indicates the risks are low, approaches vary by protocol and vendor. Emerging AI tools show promise for improving personalised risk estimation, though further development is needed for cross‐platform compatibility.
Nazli A. Moda   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy